Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa

Endokrynologia Polska

Volumn 65, Issue 1, 2014, Pages 33-39

  Ostrowska, Zofia ^a   Ziora, Katarzyna ^a   Oświȩcimska, Joanna ^a   Świȩtochowska, Elzbieta ^a   Marek, Bogdan ^a   Kajdaniuk, Dariusz ^a   Wołkowska Pokrywa, Kinga ^a   Kos Kudła, Beata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adipose tissue hormones; Anorexia nervosa; Bone metabolism; Girls; OPG; sRANKL

Indexed keywords

ADIPONECTIN; APELIN; APELIN 12; APELIN 36; CARBOXY TERMINAL TELOPEPTIDE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RESISTIN; UNCLASSIFIED DRUG; APELIN-12 PEPTIDE; APLN PROTEIN, HUMAN; BIOLOGICAL MARKER; SIGNAL PEPTIDE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD LEVEL; BODY MASS; BONE DENSITY; BONE METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; YOUNG ADULT; BLOOD; BONE; CONTROLLED CLINICAL TRIAL; METABOLISM;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; ANOREXIA NERVOSA; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; OSTEOPROTEGERIN; RANK LIGAND; RESISTIN;

EID: 84896721177     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2014.0005     Document Type: Article

References (74)

1. Klein DA, Walsh BT. Eating disorders: clinical features and pathophysiology. Physiol Behav 2004; 81: 359-374.
2. Nogal P, Lewinski A. Jadlowstret psychiczny (anorexia nervosa). Endokrynol Pol 2008; 59: 148-155.
3. Misra M, Miller KK, Bjornson J et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003; 88: 5615-5623.
4. Misra M, Soyka LA, Miller KK et al. Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab, 2003; 88: 3916-3822.
5. Misra M, Aggarwal A, Miller KK et al. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004; 114: 1574-1583.
6. Misra M, Miller KK, Almazan C et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2004; 89: 4972-4980.
7. Misra M, Miller KK, Herzog DB et al. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2004; 89: 1605-1612.
8. Misra M, Miller KK, Cord J et al. Relationships between serum adipokines, insulin levels and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab 2007; 92: 2046-2052.
9. Misra M, Klibanski A. Neuroendocrine consequence of anorexia nervosa in adolescents. Endocr Dev 2010; 17: 197-214.
10. Misra M, Klibanski A. The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism. Neuroendocrinoogy 2011; 93: 65-73.
11. Galusca B, Bossu C, Germain N et al. Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling. Osteopros Int 2006; 17: 888-896.
12. Oswiecimska J, Ziora K, Pluskiewicz W et al. Skeletal status and laboratory investigations in adolescent girls with anorexia nervosa. Bone 2007; 41: 103-110.
13. Ziora K, Oswiecimska J, Swietochowska E et al. Analiza zaleznosci pomiedzy stezeniem wybranych hormonów tkanki tluszczowej (adiponektyny i leptyny) a stezeniami hormonów tarczycy, nadnerczy i gonad w surowicy krwi u dziewczat z jadlowstretem psychicznym. Endokrynol Pediatr 2010; 9: 9-22.
14. Ziora K, Oswiecimska J, Swietochowska E et al. Ocena stezenia adiponektyny - hormonu tkanki tluszczowej w surowicy krwi u dziewczat z jadlowstretem psychicznym. Endokrynol Pediatr 2010; 9: 31-41.
15. Ziora K, Oswiecimska J, Swietochowska E et al. Ocena stezenia leptyny - hormonu tkanki tluszczowej w surowicy krwi dziewczat z jadlowstretem psychicznyn. Endokrynol Pediatr 2010; 9: 43-53.
16. Ziora K, Oswiecimska J, Swietochowska E et al. Assessment of serum apelin levels in girls with anorexia nervosa. J Clin Metab 2010; 95: 2935-2941.
17. Ziora K, Oswiecimska J, Swietochowska E et al. Assessment of serum levels resistin in girls with anorexia nervosa. Part II. Relationship between resistin and body mass index. Neuro Endocrinol Lett 2011; 32: 691-696.
18. Ziora K, Oswiecimska J, Swietochowska E et al. Assessment of serum levels resistin in girls with anorexia nervosa. Part II. Relationship between serum levels of resistin and thyroid, adrenal and gonadal hormones. Neuro Endocrinol Lett 2011; 32: 697-703.
19. Ziora K, Oswiecimska J, Swietochowska E et al. Assessment of serum visfatin levels in girls with anorexia nervosa. Clin. Endocrinol 2012; 76: 514-519.
20. Warren M. Endocrine manifestations of eating disorders. J Clin Endocrinol Metab 2011; 96: 333-343.
21. Ostrowska Z, Ziora K, Kos-Kudla B et al. Melatonin, the RANKL/RANK/ /OPG system, and bone metabolism in girls with anorexia nervosa. Endokrynol Pol 2011; 61: 117-123.
22. Ostrowska Z, Ziora K, Oswiecimska J et al. Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. Postepy Hig Med Dosw 2012; 66: 655-662.
23. Misra M, Klibanski A. Anorexia nervosa and osteoporosis. Rev Endocr Disord 2006; 7: 91-99.
24. Hadjidakis DJ, Androulakis TT. Bone remodeling. Ann N Y Acad Sci 2006; 1092: 385-396.
25. Vega D, Maalouf NM, Sakhaee K. The role of receptor activator of nuclear factor-kB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab 2007; 92 4514-4521.
26. Cornish J, Callon KE, Bava U et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 2002; 175: 405-415.
27. Holloway WR, Collier FM, Aitken CJ et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002; 17: 200-209.
28. Whipple T, Sharkey N, Demers L. Leptin and the skeleton. Clin Endocrinol 2002; 57: 701-711.
29. Whitfield JF, Morley P, Wilick GE. The control of bone growth by parathyroid hormone, leptin and statins. Crit Rev Eucaryot Exp 2002; 12: 23-51.
30. Martin A, Vittoris R, David V et al. Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspend female rats. Endocrinology 2005; 146: 3652-3659.
31. Lamghari M, Tavares L, Camboa N et al. Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts. J Cell Biochem 2006; 98: 1123-1129.
32. Thomas T, Gori F, Khosla S et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and inhibit differentiation to adipocytes. Endocrinology 1999; 140: 1630-1638.
33. Reseland JE, Syversen U, Bakke et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 2001; 16: 1426-1433.
34. Gordeladze JO, Drevson CA, Syversen U et al. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002; 85: 825-836.
35. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Current Opinion Pharmacol 2004; 4: 295-300.
36. Kanazawa I, Yamaguchi T, Yano S et al. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. Cell Biol 2007; 29: 51-61.
37. Luo XH, Guo LJ, Yuan LQ et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309: 99-109.
38. Luo XH, Guo LJ, Yuan LQ et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006; 1648-1656.
39. Thommesen L, Stunes AK, Monjo M et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006; 99: 824-834.
40. Xie H, Tang SY, Luo XH et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue 2007; 80: 201-210.
41. Tang SY, Xie H, Yuan LQ et al. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides 2007; 28: 708-718.
42. Zeng X, Yu SP, Taylor T et al. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Research 2012; 8: 357-367.
43. Gonelli S, Cafarelli C, Del Santo K et al. The relationship of grelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008; 83: 55-60.
44. Peng XD, Xie H, Zhao Q et al. Relationship between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008; 387: 31-35.
45. Tenta R, Panagiotakos DB, Fragopoulou E et al. Osteoprotegerin and nuclear factor-kappa B ligand are associated with leptin and adiponectin levels in apparently healthy women. J Musculoskelet Neuronal Interact 2010; 10: 174-179.
46. Wu N, Wang QP, Li H et al. Relationship between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 2010; 411: 771-775.
47. Mazzali G, Francesco VD, Zoico E et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 2006; 84: 1193-1199.
48. Jurimae J, Jurimae T, Leppik A et al. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008; 26: 618-623.
49. Zhang H, Xie H, Zhao Q et al. Relationship between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in postmenopausal Chinese women. J Endocrinol Invest 2010; 33: 707-711.
50. Oh KW, Lee WY, Rhee EJ et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005; 53: 131-136.
51. Zoico E, Zamboni M, Di Francesco V et al. Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol 2008; 31: 297-302.
52. Grinspoon S, Miller K, Coyle C et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999; 84: 2049-2055.
53. Soyka LA, Grinspoon S, Levitsky LL et al. The effect of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999; 84:4489-4496.
54. Soyka LA, Misra M, Frenchman A et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002; 87: 4177-4185.
55. Heer M, Mika C, Grzella I et al. Bone turnover during inpatient nutrition therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects. Am J Clin Nutr 2004; 80: 774-781.
56. Dostalova I, Smitka K, Papezova H et al. Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines. Physiol Res 2007; 56: 587-594.
57. Munoz-Calvo MT, Barrios V, Garcia de Alvaro MT et al. Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa. Scand J Clin Lab Invest 2007; 67: 387-393.
58. Legroux-Gerot I, Vignau J, Biver E et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporos Int 2010; 21: 1715-1722.
59. Weinbrenner T, Zittermann A, Gouni-Berthold I et al. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr 2003; 57: 1262-1267.
60. Mika C, Holtkamp K, Heer M et al. A 2-year prospective study of bone metabolism and bone mineral density in adolescents with anorexia nervosa. J Neural Transm 2007; 114: 1611-1618.
61. Ostrowska Z, Ziora K, Oswiecimska J et al. RANKL/RANK/OPG system and bone status in females with anorexia nervosa. Bone 2012; 50: 156-160.
62. Audi L, Vargas DM, Gussinyee M et al. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa. Pediatr Res 2002; 51: 497-504.
63. Munoz MT, Argente J. Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances. Eur Psychiat 2005; 20: 173-178.
64. Ohwada R, Hotta M, Sato K et al. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. Endocr J 2007; 54: 953-959.
65. Takeda S. Hormones and osteoporosis update. Regulation of bone remodeling by adipokines. Clin Calcium 2009; 19: 1009-1014.
66. Zofkova I. Relationship of hormones of adipose tissue and ghrelin to bone metabolism. Vnitr Lek 2009; 55: 560-564.
67. Saleem U, Mosley TH Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010; 30: 1474-1478.
68. Zillikens MC, Uitterlinden AG, van Leeuwen PTM et al. The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int 2010; 86; 116-125.
69. Delporte ML, Brichard SM, Hermans et al. Hyperadiponectinemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003; 58: 22-29.
70. Pannacciulli N, Vetter R, Milan G et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88: 1748-1752.
71. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 2005; 366: 74-85.
72. Housova J, Anderlova K, Krizova J et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005; 90: 1366-1370.
73. Modan-Moses D, Stein D, Pariente C et al. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92: 1843-1847.
74. Magni P, Dozio E, Galliera E et al. Molecular aspects of adipokine-bone interactions. Curr Mol Med 2010; 10: 522-532.